drugset / Trial / NCT01014507

Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma

NCT01014507

Phase 2 Completed 60 enrolled University of Cologne
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to test the the protective capacity of Goserelin compared with oral contraceptive

Timeline

Start
2004-01
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Goserelin Other / unclassified

Indications